Prevention of Thromboembolism with Use of Recombinant Hirudin. Results of a Double-Blind, Multicenter Trial Comparing the Efficacy of Desirudin (Revasc) with That of Unfractionated Heparin in Patients Having a Total Hip Replacement*

I. Eriksson, Bengt; Ekman, Steffan; Lindbratt, Siv; Baur, M.; Bach, Doris; Tørholm, C; Kälebo, Peter; Close, Philippe

doi:10.2106/00004623-199703000-00002

Public

Prevention of Thromboembolism with Use of Recombinant Hirudin. Results of a Double-Blind, Multicenter Trial Comparing the Efficacy of Desirudin (Revasc) with That of Unfractionated Heparin in Patients Having a Total Hip Replacement*

Published in Journal of Bone and Joint Surgery • Mar 1, 1997

Authors:

Bengt I. Eriksson

Steffan Ekman

Siv Lindbratt

Abstract

Specific inhibition of thrombin is a new method for the prevention of postoperative deep-vein thrombosis. The objective of this multicenter, randomized, double-blind study was to compare the efficacy and safety of desirudin (Revasc, CGP 39393; fifteen milligrams two times a day) with that of unfract...

Subject

Medicine

Deep vein

Heparin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!